Xeljanz

Rheumatoid Arthritis

Indications and Usage

Rheumatoid Arthritis

XELJANZ/XELJANZ XR is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF blockers.

Limitations of Use: Use of XELJANZ/XELJANZ XR in combination with biologic disease-modifying antirheumatic drugs (DMARDs) or with potent immunosuppressants such as azathioprine and cyclosporine is not recommended.

Psoriatic Arthritis

XELJANZ/XELJANZ XR is indicated for the treatment of adult patients with active psoriatic arthritis (PsA) who have had an inadequate response or intolerance to one or more TNF blockers.

Limitations of Use: Use of XELJANZ/XELJANZ XR in combination with biologic DMARDs or with potent immunosuppressants such as azathioprine and cyclosporine is not recommended.

Ankylosing Spondylitis

XELJANZ/XELJANZ XR is indicated for the treatment of adult patients with active ankylosing spondylitis (AS) who have had an inadequate response or intolerance to one or more TNF blockers.

Limitations of Use: Use of XELJANZ/XELJANZ XR in combination with biologic DMARDs or potent immunosuppressants such as azathioprine and cyclosporine is not recommended.

Ulcerative Colitis

XELJANZ/XELJANZ XR is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC), who have an inadequate response or intolerance to one or more TNF blockers.

Limitations of Use: Use of XELJANZ/XELJANZ XR in combination with biological therapies for UC or with potent immunosuppressants such as azathioprine and cyclosporine is not recommended.

Polyarticular Course Juvenile Idiopathic Arthritis

XELJANZ/XELJANZ Oral Solution is indicated for the treatment of active polyarticular course juvenile idiopathic arthritis (pcJIA) in patients 2 years of age and older who have had an inadequate response or intolerance to one or more TNF blockers.

Limitations of Use: Use of XELJANZ/XELJANZ Oral Solution in combination with biologic DMARDs or with potent immunosuppressants such as azathioprine and cyclosporine is not recommended.

More than 200,000 clinicians have integrated PrescriberPoint into their clinical workflows

HOW IT WORKS

The easy way to access samples

Create Free AccountRequest, track, and manage samples from multiple brands

Connect with a RepHave access to pharma representatives in one place to request your samples

Get your SampleManage your reps and samples in one place

WHO IS PRESCRIBERPOINT

Increasing patient access to medications they need

At PrescriberPoint, we're revolutionizing how healthcare providers get patients the medications they need. We craft solutions that help providers address the challenges in patient access and improve outcomes.

200K+Visitors Each Month

100K+Engagements Each Month

1M+Resources Viewed

WHAT HCPS ARE SAYING

This tool has transformed the way we order drug samples. Not having to interact with reps has saved us so much time and hassle. Plus, the ability to track orders in real-time is incredibly convenient. Our patients benefit greatly from the streamlined processCardiologistSan Francisco, CA

We can't imagine going back to the old way of ordering samples. The seamless integration with our existing systems and the timely scheduled deliveries have made our workflow so much more efficient. Our patients are receiving better care thanks to this tool.PediatricianChicago, IL

Ordering samples is now a breeze! The interface is user-friendly, and scheduling deliveries has never been easier. This tool has truly enhanced our patient care by ensuring they get the medications they need promptly.Family PhysicianAustin, TX

FAQs

All you need to know to order samples

Currently, PrescriberPoint is available only in the U.S, but we are excited to expand our reach in the future! Stay connected by following us or signing up for our newsletter to get the latest updates, including announcements about new market launches.

Other Rheumatoid Arthritis Samples

EntyvioTakeda Pharmaceuticals America, Inc.

OrenciaE.R. Squibb & Sons, L.L.C.

RinvoqAbbVie Inc.

XeljanzPfizer Laboratories Div Pfizer Inc

ZeposiaE.R. Squibb & Sons, L.L.C.